Filing Flows › Pelthos Therapeutics (PTHS) › Next earnings date
Pelthos Therapeutics (PTHS) earnings on Nov 12, 2026: what to expect
Pelthos Therapeutics (PTHS) is expected to report earnings on Nov 12, 2026, in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$3.33 (−$4.60 to −$1.60, 3 estimates) on revenue of $16.9M, against −$5.30 and $7.4M a year ago. It beat the EPS estimate in 25% of the quarters on record; Filing Flows' model gives it a 52% chance of beating next time.
The last report
Pelthos Therapeutics reported revenue of $15.6M for the second quarter 2026, net loss $23.4M: Net product revenues $15.4M, License and collaboration revenues $183K. How it makes money → · Every quarter →
Pelthos Therapeutics' latest quarter
Pelthos Therapeutics, Q2 2026: revenue $15.6M, operating margin -111.0%, net loss $23.4M, operating cash flow −$7.7M. The chart follows the revenue to costs, profit and cash.
Questions
When does PTHS report earnings?
Pelthos Therapeutics is expected to report on Nov 12, 2026.
What are analysts expecting from Pelthos Therapeutics?
EPS of −$3.33 and revenue of $16.9M for the quarter.
Does Pelthos Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 25% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.